Research output

  1. Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: The HOVON/LLPC Transplant BRaVE study

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

  2. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Final results of a phase 1b study of the safety and efficacy of the PI3Kδ inhibitor acalisib (GS-9820) in relapsed/refractory lymphoid malignancies

    Research output: Contribution to journal › Article › Academic › peer-review

View all (10) »

ID: 3298385